JPS5418330B2
(pl)
*
|
1973-03-16 |
1979-07-06 |
|
|
US3966905A
(en)
*
|
1973-05-29 |
1976-06-29 |
Barnes-Hind Pharmaceuticals, Inc. |
Stabilized catechol amine solutions
|
US3929989A
(en)
*
|
1974-06-14 |
1975-12-30 |
Wendt Lab Inc |
Stable suspension of calcium-magnesium oxytetracycline for intrauterine administration in treatment of bovine metritis
|
US4018889A
(en)
*
|
1976-01-02 |
1977-04-19 |
Pfizer Inc. |
Oxytetracycline compositions
|
DE2602363C2
(de)
*
|
1976-01-22 |
1984-04-12 |
Bayer Ag, 5090 Leverkusen |
Wäßrige, injizierbare Niclofolan- Formulierungen
|
GB1592053A
(en)
*
|
1976-12-16 |
1981-07-01 |
Norbrook Lab Ltd |
Oxytetracycline compositions
|
US4213963A
(en)
*
|
1978-12-14 |
1980-07-22 |
Janssen Pharmaceutica N.V. |
Fluspirilene-containing compositions
|
US4259331A
(en)
*
|
1979-04-16 |
1981-03-31 |
Pfizer Inc. |
Oxytetracycline compositions
|
US4399127A
(en)
*
|
1980-04-10 |
1983-08-16 |
Diamond Shamrock Corporation |
Injectable oxytetracycline compositions
|
US4386083A
(en)
*
|
1980-04-10 |
1983-05-31 |
Walter Hacke |
Injectable oxytetracycline compositions
|
IE74244B1
(en)
*
|
1985-10-01 |
1997-07-16 |
Bimeda Res Dev Ltd |
A process for preparing an antibiotic composition
|
US5071643A
(en)
*
|
1986-10-17 |
1991-12-10 |
R. P. Scherer Corporation |
Solvent system enhancing the solubility of pharmaceuticals for encapsulation
|
US6756365B2
(en)
*
|
1991-11-06 |
2004-06-29 |
Trustees Of Tufts College |
Reducing tetracycline resistance in living cells
|
EP0626171A1
(de)
*
|
1993-05-26 |
1994-11-30 |
Winfried Dörnhöfer |
Injektionslösung für die intravenöse oder intramuskuläre Verabreichung an Tiere
|
US6383515B2
(en)
|
1999-05-28 |
2002-05-07 |
Sawyer Maryjean |
Solvent system for enhancing solubility
|
US6849615B2
(en)
|
1999-09-14 |
2005-02-01 |
Paratek Pharmaceuticals, Inc. |
13-substituted methacycline compounds
|
US6500812B2
(en)
|
1999-09-14 |
2002-12-31 |
Paratek Pharmaceuticals, Inc. |
13-substituted methacycline compounds
|
US8106225B2
(en)
*
|
1999-09-14 |
2012-01-31 |
Trustees Of Tufts College |
Methods of preparing substituted tetracyclines with transition metal-based chemistries
|
EP1666453A1
(en)
|
1999-09-14 |
2006-06-07 |
Trustees Of Tufts College |
Methods of preparing substituted tetracyclines with transition metal-based chemistries
|
WO2001052858A1
(en)
*
|
2000-01-24 |
2001-07-26 |
Trustees Of Tufts College |
Tetracycline compounds for treatment of cryptosporidium parvum related disorders
|
US6818634B2
(en)
*
|
2000-03-31 |
2004-11-16 |
Paratek Pharmaceuticals, Inc. |
7-and 9-carbamate, urea, thiourea, thiocarbamate, and heteroaryl-amino substituted tetracycline compounds
|
EP1286954B1
(en)
|
2000-05-15 |
2004-04-14 |
Paratek Pharmaceuticals, Inc. |
7-substituted fused ring tetracycline compounds
|
US20020128238A1
(en)
*
|
2000-06-16 |
2002-09-12 |
Nelson Mark L. |
7-phenyl-substituted tetracycline compounds
|
US20040224927A1
(en)
*
|
2000-06-16 |
2004-11-11 |
Trustees Of Tufts College |
7-N-substituted phenyl tetracycline compounds
|
US20020132798A1
(en)
*
|
2000-06-16 |
2002-09-19 |
Nelson Mark L. |
7-phenyl-substituted tetracycline compounds
|
CN102336679A
(zh)
|
2000-07-07 |
2012-02-01 |
塔夫茨大学信托人 |
7-取代的四环素化合物
|
US7094806B2
(en)
*
|
2000-07-07 |
2006-08-22 |
Trustees Of Tufts College |
7, 8 and 9-substituted tetracycline compounds
|
US20050143353A1
(en)
*
|
2000-07-07 |
2005-06-30 |
Paratek Pharmaceuticals, Inc. |
13-Substituted methacycline compounds
|
CN100473644C
(zh)
|
2000-07-07 |
2009-04-01 |
塔夫茨大学信托人 |
9-取代的二甲胺四环素化合物
|
WO2002004405A2
(en)
|
2000-07-07 |
2002-01-17 |
Trustees Of Tufts College |
13-substituted methacycline compounds
|
EP1303479B1
(en)
|
2000-07-07 |
2011-04-06 |
Trustees Of Tufts College |
7-, 8- and 9-substituted tetracycline compounds
|
AU2002250331A1
(en)
*
|
2001-03-13 |
2002-09-24 |
Paratek Pharmaceuticals, Inc. |
7-pyrollyl tetracycline compounds and methods of use thereof
|
JP2005506291A
(ja)
|
2001-03-13 |
2005-03-03 |
パラテック ファーマシューティカルズ, インク. |
7,9−置換テトラサイクリン化合物
|
WO2002072031A2
(en)
|
2001-03-14 |
2002-09-19 |
Paratek Pharmaceuticals, Inc. |
Substituted tetracycline compounds as synergistic antifungal agents
|
EP1379255A2
(en)
|
2001-03-14 |
2004-01-14 |
Paratek Pharmaceuticals, Inc. |
Substituted tetracycline compounds as antifungal agents
|
CA2444899C
(en)
|
2001-04-24 |
2011-06-21 |
Paratek Pharmaceuticals, Inc. |
Substituted tetracycline compounds for the treatment of malaria
|
US8088820B2
(en)
*
|
2001-04-24 |
2012-01-03 |
Paratek Pharmaceuticals, Inc. |
Substituted tetracycline compounds for the treatment of malaria
|
EP2995610A1
(en)
|
2002-01-08 |
2016-03-16 |
Paratek Pharmaceuticals, Inc. |
4-dedimethylamino tetracycline compounds
|
EP2311451A1
(en)
|
2002-03-08 |
2011-04-20 |
Paratek Pharmaceuticals, Inc. |
Amino-methyl substituted tetracycline compounds
|
IL164180A0
(en)
|
2002-03-21 |
2005-12-18 |
Paratek Pharm Innc |
Substituted tetracycline compounds
|
CA2492273C
(en)
|
2002-07-12 |
2013-02-05 |
Paratek Pharmaceuticals, Inc. |
3, 10, and 12a substituted tetracycline compounds
|
EP2277504A1
(en)
|
2002-10-24 |
2011-01-26 |
Paratek Pharmaceuticals, Inc. |
Substituted tetracycline compounds for the treatment of malaria
|
JP2006514119A
(ja)
*
|
2003-02-12 |
2006-04-27 |
アール アンド ピー コリア カンパニー リミテッド |
溶解率が向上した難溶性薬剤の溶媒系
|
EA201001081A1
(ru)
*
|
2003-07-09 |
2011-02-28 |
Пэрэтек Фамэсьютикэлс, Инк. |
Соединения тетрациклина, фармацевтическая композиция и способ лечения чувствительного к тетрациклину состояния у субъекта
|
US20060287283A1
(en)
*
|
2003-07-09 |
2006-12-21 |
Paratek Pharmaceuticals, Inc. |
Prodrugs of 9-aminomethyl tetracycline compounds
|
EP2292590A3
(en)
|
2003-07-09 |
2012-05-02 |
Paratek Pharmaceuticals, Inc. |
Prodrugs of 9-aminomethyl tetracycline compounds
|
JP5010284B2
(ja)
*
|
2004-01-15 |
2012-08-29 |
パラテック ファーマシューティカルズ インコーポレイテッド |
テトラサイクリン化合物の芳香族a環誘導体
|
TWI261038B
(en)
*
|
2004-08-11 |
2006-09-01 |
Bo-Cheng Chen |
Bicycle gear-shifting handgrip
|
EP2301912A3
(en)
|
2004-10-25 |
2012-07-11 |
Paratek Pharmaceuticals, Inc. |
4-aminotetracyclines and methods of use thereof
|
EP2284156A3
(en)
|
2004-10-25 |
2011-09-21 |
Paratek Pharmaceuticals, Inc. |
Substituted tetracycline compounds
|
JP2008530023A
(ja)
|
2005-02-04 |
2008-08-07 |
パラテック ファーマシューティカルズ インコーポレイテッド |
テトラサイクリン化合物の11a,12−誘導体
|
DE102005012595A1
(de)
*
|
2005-03-18 |
2006-09-21 |
Lanxess Deutschland Gmbh |
Herstellung von Tri(chlorpropyl)phosphat
|
US20070093455A1
(en)
*
|
2005-07-21 |
2007-04-26 |
Paul Abato |
10-substituted tetracyclines and methods of use thereof
|
WO2007035448A2
(en)
*
|
2005-09-19 |
2007-03-29 |
Albemarle Corporation |
Highly concentrated pourable aqueous solutions of potassium ibuprofen their preparation and their uses
|
EP1991236A2
(en)
|
2006-01-24 |
2008-11-19 |
Paratek Pharmaceuticals, Inc. |
Methods of increasing oral bioavailability of tetracyclines
|
US20070244335A1
(en)
*
|
2006-04-17 |
2007-10-18 |
Teva Pharmaceutical Industries Ltd. |
Isolation of tetracycline derivatives
|
US8198470B2
(en)
*
|
2006-04-24 |
2012-06-12 |
Teva Pharmaceutical Industries Ltd. |
Crystalline form II of tigecycline and processes for preparation thereof
|
EP2857386B1
(en)
*
|
2006-04-24 |
2017-02-22 |
Teva Pharmaceutical Industries Ltd |
Tigecycline crystalline forms and processes for preparation thereof
|
EP2431469A3
(en)
*
|
2006-05-15 |
2012-05-30 |
Paratek Pharmaceuticals, Inc. |
Methods of regulating expression of genes or of gene products using substituted tetracycline compounds
|
WO2008045507A2
(en)
|
2006-10-11 |
2008-04-17 |
Paratek Pharmaceuticals, Inc. |
Substituted tetracycline compounds for treatment of bacillus anthracis infections
|
EP2452935A3
(en)
|
2006-12-21 |
2012-08-29 |
Paratek Pharmaceuticals, Inc. |
Tetracycline derivatives for the treatment of bacterial, viral and parasitic infections
|
CA2892739A1
(en)
|
2006-12-21 |
2008-07-03 |
Paratek Pharmaceuticals, Inc. |
Substituted tetracycline compounds for treatment of inflammatory skin disorders
|
EP2144614A1
(en)
|
2007-04-12 |
2010-01-20 |
Paratek Pharmaceuticals, Inc. |
Methods for treating spinal muscular atrophy using tetracycline compounds
|
AU2008246119A1
(en)
*
|
2007-04-27 |
2008-11-06 |
Paratek Pharmaceuticals, Inc. |
Methods for synthesizing and purifying aminoalkyl tetracycline compounds
|
BRPI0823405A2
(pt)
|
2007-07-06 |
2012-12-25 |
Paratek Pharm Innc |
mÉtodos para sintetizar compostos de tetraciclina substituÍda
|
WO2009111064A2
(en)
|
2008-03-05 |
2009-09-11 |
Paratek Pharmaceuticals, Inc. |
Minocycline compounds and methods of use thereof
|
PT2271348T
(pt)
|
2008-03-28 |
2018-04-16 |
Paratek Pharm Innc |
Formulação de comprimido oral de composto de tetraciclina
|
CA2721399A1
(en)
*
|
2008-04-14 |
2009-10-22 |
Paratek Pharmaceuticals, Inc. |
Substituted tetracycline compounds
|
TW202332671A
(zh)
|
2008-05-23 |
2023-08-16 |
美商Prtk Spv2公司 |
四環素化合物之甲苯磺酸鹽及同素異形體
|
WO2010011522A1
(en)
|
2008-07-21 |
2010-01-28 |
Albemarle Corporation |
High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
|
US9629809B2
(en)
|
2008-07-21 |
2017-04-25 |
Si Group, Inc. |
High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
|
EA201170425A1
(ru)
*
|
2008-09-19 |
2011-10-31 |
Паратек Фармасьютикалс, Инк. |
Тетрациклиновые соединения для лечения ревматоидного артрита и связанные с ними способы лечения
|
AU2010233089B2
(en)
|
2009-04-10 |
2016-05-26 |
Tufts Medical Center, Inc. |
Par-1 activation by metalloproteinase-1 (MMP-1)
|
EP3574908B8
(en)
|
2011-05-12 |
2024-09-11 |
Almirall LLC |
Pharmaceutical composition for oral administration comprising crystalline salts of (4s, 4as, 5ar, 12as)-4-dimethylamino-3,10,12,12a-tetrahydroxy-7-[(methoxy(methyl)amino)-methyl]-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2carboxylic acid amide
|
EP3534908A4
(en)
|
2016-11-01 |
2020-05-27 |
Paratek Pharmaceuticals, Inc. |
9-AMINOMETHYL-MINOCYCLINE COMPOUNDS AND USE THEREOF IN THE TREATMENT OF AMBULANTLY ACQUIRED BACTERIAL PNEUMONIA (CABP)
|
JP2020527607A
(ja)
|
2017-07-21 |
2020-09-10 |
アルミラール・リミテッド・ライアビリティ・カンパニーAlmirall, Llc |
非炎症性病変の処置
|